These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7904339)

  • 1. Sex differences in naloxone- and Tyr-MIF-1-induced hypoalgesia.
    Kavaliers M; Innes DG
    Peptides; 1993; 14(5):1001-4. PubMed ID: 7904339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex differences in the effects of Tyr-MIF-1 on morphine- and stress-induced analgesia.
    Kavaliers M; Innes DG
    Peptides; 1992; 13(6):1295-7. PubMed ID: 1362981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cimetidine does not change the effect of Tyr-MIF-1 (Tyr-Pro-Leu-Gly-NH2) on the opiate form of footshock-induced analgesia.
    Krowicki ZK
    Life Sci; 1991; 49(16):1163-8. PubMed ID: 1680211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Tyr-W-MIF-1 analog containing D-Pro2 discriminates among antinociception in mice mediated by different classes of mu-opioid receptors.
    Nakayama D; Watanabe C; Watanabe H; Mizoguchi H; Sakurada T; Sakurada S
    Eur J Pharmacol; 2007 Jun; 563(1-3):109-16. PubMed ID: 17343845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tyr-MIF-1 acts as an opiate antagonist in the tail-flick test.
    Kastin AJ; Stephens E; Ehrensing RH; Fischman AJ
    Pharmacol Biochem Behav; 1984 Dec; 21(6):937-41. PubMed ID: 6151669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of Tyr-MIF-1, MIF-1, and naloxone on peptide YY-induced hyperphagia.
    Hagan MM; Moss DE
    Peptides; 1994; 15(2):243-5. PubMed ID: 7911993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrathecal Tyr-W-MIF-1 produces potent, naloxone-reversible analgesia modulated by alpha 2-adrenoceptors.
    Gergen KA; Zadina JE; Kastin AJ; Paul D
    Eur J Pharmacol; 1996 Mar; 298(3):235-9. PubMed ID: 8846821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine receptor antagonists block the effect of Tyr-MIF-1 (Tyr-Pro-Leu-Gly-NH2) on the opiate form of footshock-induced analgesia.
    Krowicki ZK
    Neuropeptides; 1991 Aug; 19(4):281-5. PubMed ID: 1681456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MIF-1 and Tyr-MIF-1 antagonize morphine and opioid but not non-opioid stress-induced analgesia in the snail, Cepaea nemoralis.
    Kavaliers M
    Peptides; 1987; 8(1):1-5. PubMed ID: 2883631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential inhibitory effects of MIF-1, Tyr-MIF-1, naloxone and beta-funaltrexamine on body rotation-induced analgesia in the meadow vole, Microtus pennsylvanicus.
    Lipa SM; Kavaliers M; Ossenkopp KP
    Peptides; 1989; 10(3):493-7. PubMed ID: 2571138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tyr-MIF-1 attenuates antinociceptive responses induced by three models of stress-analgesia.
    Galina ZH; Kastin AJ
    Br J Pharmacol; 1987 Apr; 90(4):669-74. PubMed ID: 2884005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analgesic effects of Tyr-W-MIF-1: a mixed mu2-opioid receptor agonist/mu1-opioid receptor antagonist.
    Gergen KA; Zadina JE; Paul D
    Eur J Pharmacol; 1996 Nov; 316(1):33-8. PubMed ID: 8982647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory influences of MIF-1 (PLG) and Tyr-MIF-1 (YPLG) on aggression and defeat-induced analgesia in mice.
    Kavaliers M; Hirst M
    Peptides; 1986; 7(6):1007-10. PubMed ID: 2882493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Tyr-W-MIF-1 analog containing D-Pro2 acts as a selective mu2-opioid receptor antagonist in the mouse.
    Watanabe H; Nakayama D; Ito K; Watanabe C; Mizoguchi H; Fujimura T; Murayama K; Kawamura S; Sato T; Sakurada C; Sakurada T; Sakurada S
    J Pharmacol Exp Ther; 2005 Mar; 312(3):1075-81. PubMed ID: 15561796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of Tyr-MIF-1 and naloxone in two animal models involving benzodiazepine.
    Kastin AJ; Schwartzenburg D; Tsui L; Miller LG; Olson GA; Olson RD
    Brain Res Bull; 1989 Dec; 23(6):443-6. PubMed ID: 2575442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of hematopoietic progenitor cell growth by Tyr-MIF, an endogenous opiate modulator, and its degradation products.
    Horowitz D; Callahan JF; Pelus LM; Fukuda S; King AG
    Int Immunopharmacol; 2002 Apr; 2(5):721-30. PubMed ID: 12013510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential activity of the endogenous antiopiate Tyr-MIF-1 after various intensities of stress.
    Galina ZH; Kastin AJ
    Neurosci Lett; 1988 Feb; 84(3):312-6. PubMed ID: 2895440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged analgesia after intracerebroventricular Tyr-W-MIF-1 (Tyr-Pro-Trp-Gly-NH2).
    Zadina JE; Kastin AJ; Kenigs V; Bruno C; Hackler L
    Neurosci Lett; 1993 Jun; 155(2):220-2. PubMed ID: 8104325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term hyperalgesia induced by neonatal beta-endorphin and morphiceptin is blocked by neonatal Tyr-MIF-1.
    Zadina JE; Kastin AJ; Manasco PK; Pignatiello MF; Nastiuk KL
    Brain Res; 1987 Apr; 409(1):10-8. PubMed ID: 2884015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MIF-1 and Tyr-MIF-1 fail to alter benzodiazepine-induced hypothermia.
    Kastin AJ; Miller LG; Schwartzenburg DS
    Pharmacol Biochem Behav; 1989 May; 33(1):261-3. PubMed ID: 2571169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.